- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00185549
An Interactive Program to Improve Care for Children With CF
October 4, 2006 updated by: Stanford University
An Interactive Program to Improve Care for Children With Cystic Fibrosis
The purpose of this study is to evaluate the impact of an internet based program for children and families (CF.DOC) with Cystic Fibrosis on health outcomes.
The program provides for virtual visits, a personal health record, messaging with clinicians and several tools for monitoring self-care behaviors.
We anticipate that this intervention will provide for more intensive monitoring and feedback of self-care behaviors and will lead to improved health status and in particular nutritional status
Study Overview
Detailed Description
Subjects will be drawn from the pool of children who receive their care at the LPCH/Stanford Cystic Fibrosis Center.
A letter will be sent to all eligible patients inviting them to participate in the study.
This letter will also be available in the CF clinic.
All subjects who agree to participate in the study will have the study described to them by a research assistant either in person or over the phone.
Informed consent will be obtained all on subjects.
Subject who elect to participate will be randomized into either an intervention group or a control group .
Subjects in the intervention group will be given Internet Access to the program CF.DOC.
They will also be given training in how to use the program for communication with their clinicians, participating in a virtual visit and using online forms and surveys.
Subjects in the control group will be advised that they will receive usual care and will have access to CF.DOC at the completion of the study.
At the beginning of the study and at 3 month intervals subjects will be asked to complete a cystic fibrosis Quality of life survey.
At the beginning and end of the study all subjects will complete a patient experience questionnaire (CAPHS 2.0 CCC supplement ) and an CF.DOC evaluation survey.
As part of their regular care all subjects will also have their nutritional status measured and pulmonary function assessed.
subjects in the intervention group will asked to define treatment goals that are important to them (e.g.
attending camp or participating in sports) and to define health measures that will help monitor progress in meeting these goals e.g.
weekly weights or pulmonary function.
Subjects in the intervention group will be asked to log onto CF.DOC at least one time per month.
Study Type
Interventional
Enrollment
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Palo Alto, California, United States, 94304
- Lucile Packard Children's Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 month to 21 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria: Patients with Cystic Fibrosis diagnosed by a sweat chloride analysis and/or testing for the CF gene between the ages of 1 month and 21 years of age. Patients must also be English speaking -
Exclusion Criteria: Non-English speaking patients
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Educational/Counseling/Training
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
Improvement in nutritional status
|
|
Improvement in CF related quality of life
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
Phone utilization
|
|
COmponents of program liked and dis-liked
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: David A Bergman, MD, Stanford University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2004
Study Completion
September 1, 2005
Study Registration Dates
First Submitted
September 12, 2005
First Submitted That Met QC Criteria
September 12, 2005
First Posted (Estimate)
September 16, 2005
Study Record Updates
Last Update Posted (Estimate)
October 5, 2006
Last Update Submitted That Met QC Criteria
October 4, 2006
Last Verified
September 1, 2005
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 78910
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.